A tyrosine-phosphorylated protein of 140 kD is constitutively associated with the phosphotyrosine binding domain of Shc and the SH3 domains of Grb2 in acute myeloid leukemia cells

Blood

Volumn 89, Issue 6, 1997, Pages 2024-2035

  Jücker, Manfred ^b   Schiffer, Charles A ^b   Feldman, Ricardo A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; GENE PRODUCT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TRANSFORMING PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; COMPLEX FORMATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0242471592     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.6.2024     Document Type: Article

References (79)

1. Griffin JD, Löwenberg B: Clonogenic cells in acute myeloblastic leukemia. Blood 68:1185, 1986
2. Land H, Parada LF, Weinberg RA: Cellular oncogenes and multistep carcinogenesis. Science 222:771, 1983
3. Hunter T: Cooperation between oncogenes. Cell 64:249, 1991
4. Sawyers CL, Denny CT, Witte ON: Leukemia and the disruption of normal hematopoiesis. Cell 64:337, 1991
5. Rowley JD: Identification of the constant chromosome regions involved in human hematologic malignant disease. Science 216:749, 1982
6. Rabbitts TH: Chromosomal translocations in human cancer. Nature 372:143, 1994
7. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M: t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 88:10431, 1991
8. de The H, Lavau C, Marchio A, de Chomienne C, Degos L, Dejean A: The PML-RARα fusion mRNA generated by the t(15/17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675, 1991
9. Kakizuka A, Miller WH, Umesono K, Warrell RP, Frankel SR, Murty VVVS, Dmitrovsky E, Evans RM: Chromosomal translocation t(15,17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 66:663, 1991
10. Nucifora G, Rowley JD: AML1 and the 8;21 3:21 translocations in acute and chronic myeloid leukemia. Blood 86:1, 1995
11. Rabbitts TH: Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell 67:641, 1991
12. Metcalf D: The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339:27, 1989
13. Miyajima A, Kitamura T, Harada N, Yokota T, Arai K: Cytokine receptors and signal transduction. Annu Rev Immunol 10:295, 1992
14. Löwenberg B, Touw IP: Hematopoietic growth factors and their receptors in acute leukemia. Blood 81:281, 1993
15. Young DC, Griffin JD: Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood 68:1178, 1986
16. Lanfrancone L, Mannoni P, Pelusque MJ, Care A, Peschle C, Grignani F, Pelicci PG: Expression pattern of c-fes oncogene mRNA in human myeloid cells. Int J Cancer 4:35, 1989
17. Brach MA, Gauer E, Ludwig WD, Ganser A, Mertelsmann R, Herrmann F: Expression of the c-fes proto-oncogene in granulocyte-macrophage colony-stimulating factor-dependent acute myeloid leukemia cells grown autonomously. Int J Cell Cloning 9:89, 1991
18. Areces LB, Jücker M, San Miguel JA, Mui A, Miyajima A, Feldman RA: Ligand-dependent transformation by the receptor for human granulocyte/macrophage colony-stimulating factor and tyrosine phosphorylation of the receptor β subunit. Proc Natl Acad Sci USA 90:3963, 1993
19. Chang JM, Metcalf D, Lang RA, Gonda RJ, Johnson GR: Nonneoplastic hematopoetic myeloproliferative syndrome induced by dysregulated multi-CSF (IL-3) expression. Blood 73:1487, 1989
20. Johnson GR, Gonda TJ, Metcalf D, Hariharan IK, Cory S: A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor. EMBO J 8:441, 1989
21. Wong PMC, Chung S, Dunbar CE, Bodine DM, Ruscetti S, Nienhuis AW: Retrovirus-mediated transfer and expression of the interleukin-3 gene in mouse hematopoietic cells result in a myeloproliferative disorder. Mol Cell Biol 9:798, 1989
22. Sherr CJ: Colony-stimulating factor-1 receptor. Blood 75:1, 1990
23. Longmore GD, Lodish HF: An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: A cytokine receptor superfamily oncogene. Cell 67:1089, 1991
24. Ridge SA, Worwood M, Oscier D, Jacobs A, Padua RA: FMS mutations in myelodysplastic leukemic and normal subjects. Proc Natl Acad Sci USA 87:1377, 1990
25. Ikeda H, Kanakura Y, Tamaki T, Kuriu A, Kitayama H, Ishikawa J, Kanayama Y, Yonezawa T, Tarui S, Griffin JD: Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood 78:2962, 1991
26. Barbacid M: ras genes. Annu Rev Biochem 56:779, 1987
27. Bos JL: ras oncogenes in human cancer: A review. Cancer Res 49:4682, 1989
28. Bos JL, Verlaan-de Vries M, van der Eb AJ, Janssen JWG, Delwel R, Löwenberg B, Colly LP: Mutations in N-ras predominate in acute myeloid leukemia. Blood 69:1237, 1987
29. Janssen JWG, Steenvoorden ACM, Lyons J, Anger B, Böhlke JU, Bos JL, Seliger H, Bartram CR: RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc Natl Acad Sci USA 84:9228, 1987
30. Farr CJ, Saiki RK, Erlich HA, McCormick F, Marshall CJ: Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci USA 85:1629, 1988
31. Mandanas RA, Leibowitz DS, Gharebaghi K, Tauchi T, Burgess GS, Miyazawa K, Jayaram HN, Boswell HS: Role of p21 RAS in bcr-abl transformation of murine myeloid cells. Blood 82:1838, 1993
32. Kinoshita T, Yokota T, Arai K, Miyajima A: Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors. EMBO J 14:266, 1995
33. Kinoshita T, Yokota T, Arai K, Miyajima A: Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells. Oncogene 10:2207, 1995
34. Sawyers CL, Denny CT: Chronic myelomonocytic leukemia: Tel-a-kinase what ets all about. Cell 77:171, 1994
35. Schlessinger J: How receptor tyrosine kinases activate Ras. Trends Biol Sci 18:273, 1993
36. Satoh T, Nakafuku M, Miyajima A, Kaziro Y: Involvement of ras p21 protein in signal-transduction pathways from interleukin-2, interleukin-3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. Proc Natl Acad Sci USA 88:3314, 1991
37. Rozakis-Adcock, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci PG, Schlessinger J, Pawson T: Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360:689, 1992
38. Boguski MS, McCormick F: Proteins regulating Ras and its relatives. Nature 366:643, 1993
39. Aronheim A, Engelberg D, Li N, Al-Alawi N, Schlessinger J, Karin M: Membrane targeting of the nucleotide exchange factor SOS is sufficent for activating the Ras signalling pathway. Cell 78:949, 1994
40. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Bar-Sagi D, Schlessinger J: The SH2 and SH3 Domain-containing protein Grb2 links receptor tyrosine kinases to ras signaling. Cell 70:431, 1992
41. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA: Association of SOS Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363:45, 1993
42. Ravichandran KS, Lorenz U, Shoelson SE, Burakoff SJ: Interaction of Shc with Grb2 regulates association of Grb2 with mSOS. Mol Cell Biol 15:593, 1995
43. Batzer AG, Rotin D, Urena JM, Skolnik EY, Schlessinger J: Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor. Mol Cell Biol 14:5192, 1994
44. Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I, Grignani F, Pawson T, Pelicci PG: A novel transforming protein (Shc) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93, 1992
45. Segatto O, Pelicci G, Giuli S, Digiesi G, Di Fiore PP, McGlade J, Pawson T, Pelicci PG: Shc products are substrates of erbB-2 kinase. Oncogene 8:2105, 1993
46. Batzer AG, Blaikie P, Nelson K, Schlessinger J, Margolis B: The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor. Mol Cel Biol 15:4403, 1995
47. Blaikie P, Immanuel D, Wu J, Li N, Yajnik V, Margolis B: A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. J Biol Chem 269:32031, 1994
48. Kavanaugh W, Williams LT: An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science 266:1862, 1994
49. van der Geer P, Wiley S, Lai VK, Olivier JP, Gish GD, Stephens R, Kaplan D, Shoelson S, Pawson T: A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides. Curr Biol 5:404, 1995
50. Gustafson TA, He W, Craparo A, Schaub CD, O'Neill TJ: Phosphotyrosine-dependent interaction of Shc and IRS-1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol Cell Biol 15:2500, 1995
51. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky A, Lechleider R, Neel BG, Birge RB, Fajardo JE, Chou MM Hanafusa H, Schaffhausen B, Cantley L: SH2 domains recognize specific phosphopeptide sequences. Cell 72:767, 1993
52. Bork P, Margolis B: A phosphotyrosine interaction domain. Cell 80:693, 1995
53. Lanfrancone L, Pelicci G, Brizzi MF, Arouica MG, Casciari C, Giuli S, Pegoraro L, Pawson T, Pelicci PG: Overexpression of Shc proteins potentiates the proliferative response to the granulocyte-macrophage colony-stimulating factor and recruitment of Grb2/SoS and Grb2/p140 complexes to the β receptor subunit. Oncogene 10:907, 1995
54. McGlade J, Cheng A, Pelicci G, Pelicci PG, Pawson T: Shc proteins are phosphorylated and regulated by the v-src and v-fps protein-tyrosine kinases. Proc Natl Acad Sci USA 89:8869, 1992
55. BCR/Abl. J Biol Chem 18:5016, 1994
56. Cutler RL, Liu L, Damen JE, Krystal G: Multiple cytokines induce the tyrosine phosporylation of Shc and its association with Grb2 in hemopoietic cells. J Biol Chem 268:21463, 1993
57. Lioubin MN, Myles GM, Carlberg K, Bowtell D, Rohrschneider LR: Shc, Grb2, SOS1, and a 150-kilodalton tyrosine-phosphorylated protein form complexes with fms in hematopoietic cells. Mol Cell Biol 14:5682, 1994
58. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao Y, Miyazono K, Urabe A, Takaku F: Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 140:323, 1989
59. Feldman RA, Lowy DR, Vass WC, Velu TJ: A highly efficient retroviral vector allows detection of the transforming activity of the human c-fps/fes proto-oncogene. J Virol 63:5469, 1989
60. Morgan C, Pollard JW, Stanley ER: Isolation and characterization of a cloned growth factor dependent macrophage cell line, BAC1.2F5. J Cell Physiol 130:420, 1987
61. c by IL-1 and tumor necrosis factor-α. Blood 80:2215, 1992
62. Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, Barsagi D, Margolis B, Schlessinger J: Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363:85, 1993
63. Areces LB, Dello Sbarba P, Jücker M, Stanley ER, Feldman RA: Functional specificity of cytoplasmic and transmembrane tyrosine kinases: Identification of 130 and 75 kda substrates of c-fps/fes tyrosine kinase in macrophages. Mol Cell Biol 14:4606, 1994
64. Jücker M, Feldman RA: Identification of a new adapter protein that may link the common β subunit of the receptor for granulocyte/macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 to phosphatidylinositol 3-kinase. J Biol Chem 270:27817, 1995
65. Silvennoinen O, Witthuhn BA, Quelle PW, Cleveland JL, Yi T, Ihle JN: Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci USA 90:8429, 1993
66. C chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 14:4335, 1994
67. Sakamaki K, Miyajima I, Kitamura T, Miyajima A: Critical cytoplasmic domains of the common β subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J 11:3541, 1992
68. Sato N, Sakamaki K, Terada N, Arai K, Miyajima A: Signal transduction by the high affinity GM-CSF receptor: Two distinct cytoplasmic regions of the common β subunit responsible for different signaling. EMBO J 12:4181, 1993
69. Pelicci G, Lanfrancone L, Salcini AE, Romano A, Mele S, Borrello MG, Segatto O, Di Fiore PP, Pelicci PG: Constitutive phosphorylation of Shc proteins in human tumors. Oncogene 11:899, 1995
70. Damen JE, Liu L, Cutler RL, Krystal G: Erythopoetin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein. Blood 82:2296, 1993
71. Liu L, Damen JD, Cutler R, Krystal G: Multiple cytokines stimulate the binding of a common 145-kilodalton protein to Shc at the Grb2 recognition site of Shc. Mol Cell Biol 14:6926, 1994
72. Damen JE, Liu L, Rosten P, Humphries RK, Jefferson AB, Majerus PW, Krystal G: The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc Natl Acad Sci USA 93:1689, 1996
73. Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev 10:1084, 1996
74. Jücker M, Feldman RA: Novel adapter proteins that link the human GM-CSF receptor to the phosphatidylinositol 3-kinase and Shc/Grb2/ras signaling pathways. Curr Top Microbiol Immunol 211:67, 1996
75. Weng Z, Thomas S, Rickles RJ, Taylor JA, Brauer AW, Seidel-Dugan C, Michael WM, Deyfuss G, Brugge JS: Identification of Src, Fyn, and Lyn SH3-binding proteins: Implications for a function of SH3 domains. Mol Cell Biol 14:4509, 1994
76. Egan SE, Weinberg RA: The pathway to signal achievement. Nature 365:781, 1993
77. Marshall CJ: Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179, 1995
78. Salcini AE, McGlade J, Pelicci G, Nicoletti I, Pawson T, Pelicci PG: Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene 9:2827, 1994
79. Baldari CT, Pelicci G, Di Somma MM, Milia E, Giuli S, Pelicci PG, Telford JL: Inhibition of CD4/p56lck signaling by a dominant negative mutant of the Shc adaptor protein. Oncogene 10:1141, 1995